NNMDA, NITR collaborate on indigenous sleeping sickness, river blindness medicine
By Ijeoma Olorunfemi
The Nigerian Natural Medicines Development Agency (NNMDA) is collaborating with the Nigerian Institute for Onchocerciasis, Trypanosomiasis and Research (NITR) to produce indigenous medicines for onchocerciasis and trypanosomiasis.
Also known as sleeping sickness, trypanosomiasis is an infection that spreads from the bites of infected tsetse flies. Advanced symptoms include drowsiness.
Onchocerciasis, popularly known as river blindness, is spread by repeated bites from infected black flies.
The Director-General, NNMDA, Prof. Martins Emeje, said in Abuja during a working visit by Director-General, NITR, Dr Joachim Ajakaiye, that partnership was vital for agencies that share similar visions.
“As an agency, we already have products, natural medicines for livestock diseases, different livestock diseases.
“The visit by the NITR team to partner with us in making natural medicines for onchocerciasis is one of the best things that is going to happen to us as a nation.
“As you know, drugs are not available for onchocerciasis, it is a neglected tropical disease; it is not a disease of interest to so many people in Europe and the West,” he said.
Emeje said that the agency was working on establishing a Public-Private Partnership model (PPP), adding that human capacity and capability were abundant in public institutions.
The NNMDA chief said the agency had the legal framework to conduct research and development into natural medicines for humans, animals and plants hence the need for the partnership.
He said the solutions to the challenges facing Africa could be found within the continent adding that it required expertise collaborations.
“We are going to embark on rigorous research for the development of natural medicines for onchocerciasis because we have our own rich plants, animal and mineral biodiversity that are potent against it.
“What we are bringing to the table is the expertise of making the medicine which they don’t have.
“They will bring the expertise from their own area, which is in the area of the pathophysiology, epidemiology and knowledge of onchocerciasis.
Ajakaiye on his part said the institution’s mandates included researching on trypanosomiasis and onchocerciasis, two neglected tropical diseases.
“In the process of working on alternative drugs, we have one of our researchers working on getting bio-molecule based on nano-particle emulsion to get alternative therapy for us, a repellent for the vector of onchocerciasis.
“It is in the process of getting this, to achieve a detailed human capacity and capability, that we have decided to come and collaborate with NNMDA,” he said.
Ajakaiye said the agencies would draft a Memorandum of Understanding to consolidate the collaboration. (NAN) (www.nannews.ng)
Edited by Uche Anunne